Indirect costs account for half of the total costs of an osteoporotic fracture: a prospective evaluation
- 498 Downloads
Data on direct and indirect costs of clinical fractures in 116 osteoporotic patients 50 years and older were prospectively collected using cost diaries. Indirect costs accounted for roughly half of the total costs, with a contribution of at least 81 % of these costs in employed patients.
The aim of this prospective study was to gain insight into the current total costs of clinical fractures in osteoporotic patients aged 50 years and older.
In a study in the Netherlands, patients prospectively filled out cost diaries every 3 months, during 1 year after a clinical fracture. Primary analyses were performed on those patients with all four cost diaries returned. In-depth analyses of indirect costs were performed, dividing results for employed and unemployed patients. Sensitivity analyses using imputation techniques were performed on patients who returned two or three diaries
Of the 116 included patients, 69 completed all four diaries, 24 only two or three, and 23 patient completed one or no diaries. For all fractures, approximately 50 % of the total costs were due to indirect costs; employed patients contributed for at least 81 % of the indirect cost. Humerus fractures were most expensive with a total 1-year cost of €16.841 per patient. Indirect costs in the group with clinical spine fractures were highest (€12.522), accounting for 89.1 % of the total costs for this fracture.
Indirect costs account for roughly half of the total costs of clinical fractures, which are largely related to sick leave. When performing cost analyses in fracture patients, we advise a societal perspective in which indirect costs are also considered, and to apply a patient derived prospective data collection method to get a ‘true’ and complete image of the total costs due to clinical fractures.
KeywordsClinical and osteoporotic fractures Cost diary Fracture liaison service Indirect costs
Conflicts of interest
- 1.Sambrook P, Cooper C (2006) Osteoporos Lancet 367:2010–2018Google Scholar
- 2.Nederlandse Vereniging voor Reumatologie. (2011) CBO richtlijn osteoporose en fractuurpreventieGoogle Scholar
- 5.Roux C, Wyman A, Hooven FH, Gehlbach SH, Adachi JD, Chapurlat RD, Compston JE, Cooper C, Ez-Perez A, Greenspan SL, Lacroix AZ, Netelenbos JC, Pfeilschifter J, Rossini M, Saag KG, Sambrook PN, Silverman S, Siris ES, Watts NB, Boonen S (2012) Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women (GLOW). Osteoporos Int 23:2863–2871PubMedCrossRefGoogle Scholar
- 9.Piscitelli P, Gimigliano F, Gatto S, Marinelli A, Gimigliano A, Marinelli P, Chitano G, Greco M, Di PL, Sbenaglia E, Benvenuto M, Muratore M, Quarta E, Calcagnile F, Coli G, Borgia O, Forcina B, Fitto F, Giordano A, Distante A, Rossini M, Angeli A, Migliore A, Guglielmi G, Guida G, Brandi ML, Gimigliano R, Iolascon G (2010) Hip fractures in Italy: 2000–2005 extension study. Osteoporos Int 21:1323–1330PubMedCrossRefGoogle Scholar
- 10.Parthan A, Kruse M, Yurgin N, Huang J, Viswanathan HN, Taylor D. (2013) Cost Effectiveness of Denosumab versus Oral Bisphosphonates for Postmenopausal Osteoporosis in the US. Appl Health Econ Health PolicyGoogle Scholar
- 16.Eekman D, van Helden S, Huisman A, Verhaar H, Bultink I, Geusens P, Lips P, Lems W. (2013) Optimizing fracture prevention: the fracture liaison service, an observational study. Osteoporos Int. doi: 10.1530/boneabs.1.PP43
- 19.Medicijnkosten. Themasite van het College voor zorgverzekeringen (CVZ). (2012) Medication costs. Accessed on 26 June 2012Google Scholar
- 28.Hopkins RB, Tarride JE, Leslie WD, Metge C, Lix LM, Morin S, Finlayson G, Azimaee M, Pullenayegum E, Goeree R, Adachi JD, Papaioannou A, Thabane L (2013) Estimating the excess costs for patients with incident fractures, prevalent fractures, and nonfracture osteoporosis. Osteoporos Int 24:581–593PubMedCrossRefGoogle Scholar